A great time to invest in baby Boomer's hepatitis C!

Authors


  • Potential conflict of interest: Dr. Vachon consults for Merck, Gilead, and Vertex. Dr. Dieterich consults for, advises, and is on the speakers' bureau of Gilead, B.I., and Bristol-Myers Squibb.

No abstract is available for this article.

Ancillary